AK-R215

· Alvogen Korea

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AK-R215, covering 2017-10-25 to 2017-10-25. Get the full timeline:

Most recent: Clinical Trial Update: AK-R215 Pharmacokinetic Study Phase I [Phase 1]